Piflufolastat F 18

N/A

Report date: 2025/11/25 15:53:04
NME

Base Information

Drug NamePiflufolastat F 18
Drug Alias NamePyLDCFPyL-18FFluorine-18-DCFPyL[18F]DCFPyLPylarify +[6] 
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsPositron-emission tomography enhancers
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsMetastatic breast cancerDiagnostic agentsCastration-Sensitive Prostate Neoplasms +[10] 
Global Approved IndicationsDiagnostic agentsProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/05/26
Country/TerritoryCanadaUnited StatesSwitzerland +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesCurium IncCurium Pet FranceSidney Kimmel Cancer Center +[9] 
Inactive CompaniesNational Institutes Of HealthColumbia UniversityStony Brook University +[6] 
Active IndicationsMetastatic breast cancerDiagnostic agentsCastration-Sensitive Prostate Neoplasms +[9] 
Inactive IndicationsGenital Neoplasms, Female

Other Information

ATC CodeV09
Related LinksN/A